HAE - Haemonetics Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 3/30/2019 3/31/2018 4/1/2017 4/2/2016
Total Revenue 967,579 903,923 886,116 908,832
Cost of Revenue 528,873 492,015 507,622 502,918
Gross Profit 438,706 411,908 378,494 405,914
Operating Expenses
Research Development 35,714 39,228 37,556 44,965
Selling General and Administrative 298,277 316,523 301,726 317,223
Non Recurring - - - -
Others - - - -
Total Operating Expenses 862,864 847,766 846,904 865,106
Operating Income or Loss 104,715 56,157 39,212 43,726
Income from Continuing Operations
Total Other Income/Expenses Net -31,082 3,475 -66,688 -97,142
Earnings Before Interest and Taxes 104,715 56,157 39,212 43,726
Interest Expense -13,100 -7,700 -7,900 -8,500
Income Before Tax 73,633 59,632 -27,476 -53,416
Income Tax Expense 18,614 14,060 -1,208 2,163
Minority Interest - - - -
Net Income From Continuing Ops 55,019 45,572 -26,268 -55,579
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 55,019 45,572 -26,268 -55,579
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 55,019 45,572 -26,268 -55,579